Logothetis CJ - Search Results

1

Effects of abiraterone acetate on androgen signaling in castrate-resistant prostate cancer in bone.

Efstathiou E, Titus M, Tsavachidou D, Tzelepi V, Wen S, Hoang A, Molina A, Chieffo N, Smith LA, Karlou M, Troncoso P, Logothetis CJ. Efstathiou E, et al. Among authors: logothetis cj. J Clin Oncol. 2012 Feb 20;30(6):637-43. doi: 10.1200/JCO.2010.33.7675. Epub 2011 Dec 19. J Clin Oncol. 2012. PMID: 22184395 Free PMC article. Clinical Trial.

2

Phase II study of coumarin and cimetidine in patients with metastatic renal cell carcinoma.

Dexeus FH, Logothetis CJ, Sella A, Fitz K, Amato R, Reuben JM, Dozier N. Dexeus FH, et al. Among authors: logothetis cj. J Clin Oncol. 1990 Feb;8(2):325-9. doi: 10.1200/JCO.1990.8.2.325. J Clin Oncol. 1990. PMID: 2137163

3

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.

Logothetis CJ, Dexeus FH, Finn L, Sella A, Amato RJ, Ayala AG, Kilbourn RG. Logothetis CJ, et al. J Clin Oncol. 1990 Jun;8(6):1050-5. doi: 10.1200/JCO.1990.8.6.1050. J Clin Oncol. 1990. PMID: 2189954 Clinical Trial.

4

Successful treatment of pure endodermal sinus tumors in adult men.

Chong CD, Logothetis CJ, von Eschenbach AC, Ayala AG, Samuels ML. Chong CD, et al. Among authors: logothetis cj. J Clin Oncol. 1988 Feb;6(2):303-7. doi: 10.1200/JCO.1988.6.2.303. J Clin Oncol. 1988. PMID: 2448426

5

Interferon alternating with chemotherapy for patients with metastatic renal cell carcinoma.

Dexeus FH, Logothetis CJ, Sella A, Finn L. Dexeus FH, et al. Among authors: logothetis cj. Am J Clin Oncol. 1989 Aug;12(4):350-4. doi: 10.1097/00000421-198908000-00015. Am J Clin Oncol. 1989. PMID: 2667326 Clinical Trial.

6

Adjuvant cyclophosphamide, doxorubicin, and cisplatin chemotherapy for bladder cancer: an update.

Logothetis CJ, Johnson DE, Chong C, Dexeus FH, Sella A, Ogden S, Smith T, Swanson DA, Babaian RJ, Wishnow KI, et al. Logothetis CJ, et al. J Clin Oncol. 1988 Oct;6(10):1590-6. doi: 10.1200/JCO.1988.6.10.1590. J Clin Oncol. 1988. PMID: 3171626

7

Phase II study of ketoconazole combined with weekly doxorubicin in patients with androgen-independent prostate cancer.

Sella A, Kilbourn R, Amato R, Bui C, Zukiwski AA, Ellerhorst J, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. J Clin Oncol. 1994 Apr;12(4):683-8. doi: 10.1200/JCO.1994.12.4.683. J Clin Oncol. 1994. PMID: 7512126 Clinical Trial.

8

The results of a phase II randomized trial comparing 5-fluorouracil and 5-fluorouracil plus alpha-interferon: observations on the design of clinical trials for androgen-independent prostate cancer.

Daliani DD, Eisenberg PD, Weems J, Lord R, Fueger R, Logothetis CJ. Daliani DD, et al. Among authors: logothetis cj. J Urol. 1995 May;153(5):1587-91. J Urol. 1995. PMID: 7536271 Clinical Trial.

9

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial.

Logothetis CJ, Finn LD, Smith T, Kilbourn RG, Ellerhorst JA, Zukiwski AA, Sella A, Tu SM, Amato RJ. Logothetis CJ, et al. J Clin Oncol. 1995 Sep;13(9):2272-7. doi: 10.1200/JCO.1995.13.9.2272. J Clin Oncol. 1995. PMID: 7666085 Clinical Trial.

10

Phase I study of tumor necrosis factor plus actinomycin D in patients with androgen-independent prostate cancer.

Sella A, Aggarwal BB, Kilbourn RG, Bui CA, Zukiwski AA, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. Cancer Biother. 1995 Fall;10(3):225-35. doi: 10.1089/cbr.1995.10.225. Cancer Biother. 1995. PMID: 8547961 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

423 results

Search Page

Filters